Yanek Jimenez Andrade, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitogen-Activated Protein Kinase 14 | 2 | 2022 | 29 | 0.950 |
Why?
|
| Dermatitis, Atopic | 1 | 2022 | 731 | 0.470 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2013 | 110 | 0.440 |
Why?
|
| Lipectomy | 1 | 2022 | 113 | 0.370 |
Why?
|
| Pyrithioxin | 1 | 2008 | 1 | 0.320 |
Why?
|
| Cryosurgery | 1 | 2022 | 474 | 0.280 |
Why?
|
| Immunoglobulin E | 1 | 2013 | 1502 | 0.280 |
Why?
|
| Mast Cells | 1 | 2013 | 1392 | 0.260 |
Why?
|
| Transcription Factors | 1 | 2022 | 12129 | 0.200 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 3492 | 0.200 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2008 | 1119 | 0.200 |
Why?
|
| Analgesics | 1 | 2008 | 1070 | 0.190 |
Why?
|
| Erythroid Cells | 1 | 2020 | 238 | 0.160 |
Why?
|
| Keratinocytes | 1 | 2022 | 791 | 0.150 |
Why?
|
| Neutrophil Infiltration | 1 | 2020 | 390 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 11 | 1 | 2016 | 5 | 0.140 |
Why?
|
| Oxidative Stress | 1 | 2008 | 3113 | 0.140 |
Why?
|
| Receptors, IgG | 1 | 2020 | 559 | 0.140 |
Why?
|
| Interleukin-4 | 1 | 2020 | 1149 | 0.130 |
Why?
|
| Arthritis | 1 | 2020 | 680 | 0.120 |
Why?
|
| Cryotherapy | 1 | 2022 | 159 | 0.100 |
Why?
|
| Phosphorylation | 1 | 2022 | 8321 | 0.090 |
Why?
|
| DNA Damage | 1 | 2020 | 2449 | 0.090 |
Why?
|
| Mice | 7 | 2022 | 81533 | 0.090 |
Why?
|
| Melanoma, Experimental | 1 | 2013 | 560 | 0.090 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 1486 | 0.080 |
Why?
|
| Subcutaneous Fat | 1 | 2022 | 393 | 0.080 |
Why?
|
| Oxadiazoles | 1 | 2008 | 94 | 0.080 |
Why?
|
| Streptozocin | 1 | 2008 | 194 | 0.080 |
Why?
|
| Indomethacin | 1 | 2008 | 325 | 0.070 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2016 | 2547 | 0.070 |
Why?
|
| Animals | 8 | 2022 | 168467 | 0.070 |
Why?
|
| Neutrophils | 1 | 2020 | 3767 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2022 | 22172 | 0.070 |
Why?
|
| Proteomics | 1 | 2020 | 3848 | 0.070 |
Why?
|
| Quinoxalines | 1 | 2008 | 296 | 0.070 |
Why?
|
| Naltrexone | 1 | 2008 | 317 | 0.060 |
Why?
|
| Mice, Knockout | 3 | 2020 | 14416 | 0.060 |
Why?
|
| Rats, Wistar | 1 | 2008 | 1848 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2016 | 3080 | 0.050 |
Why?
|
| Software | 1 | 2017 | 4434 | 0.050 |
Why?
|
| Inflammation | 1 | 2022 | 10773 | 0.050 |
Why?
|
| Swine | 1 | 2022 | 5915 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 18253 | 0.050 |
Why?
|
| Melanoma | 1 | 2020 | 5709 | 0.050 |
Why?
|
| Rats | 1 | 2008 | 23741 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 6214 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 1616 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 2057 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2020 | 23447 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2022 | 64684 | 0.020 |
Why?
|
| Humans | 4 | 2022 | 761572 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2020 | 11530 | 0.010 |
Why?
|
| Male | 1 | 2013 | 360842 | 0.010 |
Why?
|
| Female | 1 | 2008 | 392686 | 0.010 |
Why?
|